PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
70.18%
Positive revenue growth while FSLR is negative. John Neff might see a notable competitive edge here.
111.14%
Positive gross profit growth while FSLR is negative. John Neff would see a clear operational edge over the competitor.
444.77%
Positive EBIT growth while FSLR is negative. John Neff might see a substantial edge in operational management.
1553.08%
Positive operating income growth while FSLR is negative. John Neff might view this as a competitive edge in operations.
656.87%
Positive net income growth while FSLR is negative. John Neff might see a big relative performance advantage.
580.95%
Positive EPS growth while FSLR is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
580.95%
Positive diluted EPS growth while FSLR is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.19%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.05%
Slight or no buyback while FSLR is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
946.34%
OCF growth above 1.5x FSLR's 41.01%. David Dodd would confirm a clear edge in underlying cash generation.
792.23%
FCF growth above 1.5x FSLR's 25.00%. David Dodd would verify if the firm’s strategic investments yield superior returns.
12104.02%
10Y revenue/share CAGR 1.25-1.5x FSLR's 9080.65%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
678.10%
5Y revenue/share CAGR under 50% of FSLR's 2483.59%. Michael Burry would suspect a significant competitive gap or product weakness.
229.29%
3Y revenue/share CAGR 1.25-1.5x FSLR's 167.24%. Bruce Berkowitz might see better product or regional expansions than the competitor.
11014.38%
OCF/share CAGR of 11014.38% while FSLR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
70160.74%
OCF/share CAGR of 70160.74% while FSLR is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
820.71%
3Y OCF/share CAGR above 1.5x FSLR's 208.73%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
1219.73%
Net income/share CAGR at 50-75% of FSLR's 1992.54%. Martin Whitman might question if the firm’s product or cost base lags behind.
5895.86%
5Y net income/share CAGR above 1.5x FSLR's 1345.55%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
2361.57%
3Y net income/share CAGR above 1.5x FSLR's 118.25%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
56.12%
Below 50% of FSLR's 15041.78%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
51.21%
Below 50% of FSLR's 177.07%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.95%
Our AR growth while FSLR is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
9.65%
Inventory growth well above FSLR's 8.93%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
16.18%
Asset growth above 1.5x FSLR's 4.25%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
16.24%
BV/share growth above 1.5x FSLR's 4.88%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
43.49%
We have some new debt while FSLR reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
5.33%
R&D dropping or stable vs. FSLR's 28.54%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
53.53%
SG&A growth well above FSLR's 16.55%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.